Lu et al. found that berberine, a natural product that is widely used to treat hyperlipoidemia and intestinal diseases, promoted the up-regulation of TRAF1 levels in treated HeLa cells, demonstrating the involvement of the TRAF1-related death receptor pathway in the process of berberine-induced apoptosis [35]. Here, TRAF1 is linked to intestinal disorder.